J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1417-1421.e1. doi: 10.1016/j.japh.2022.02.016. Epub 2022 Feb 26.
The presence of bacteria in the urine, without coinciding symptoms of infection, is classified as asymptomatic bacteriuria (ASB). Although ASB is common, the Infectious Disease Society of America guidelines discourage its treatment because most patients have no adverse health effects and derive no benefit from antibiotic drugs. Despite these guidelines, patients with ASB frequently receive antibiotic drugs, establishing the need for antimicrobial stewardship interventions.
This study aimed to describe implementation of an antibiotic stewardship campaign targeting proper identification and management of ASB within the ambulatory care setting.
An antibiotic stewardship campaign was implemented to facilitate prescribing behavior change. An academic detailer performed education outreach to primary care providers (PCPs). Robust conversation was used to deliver key messages focusing on PCP specific improvements. At the completion of the encounter, each PCP was provided with a unique "superhero" name and asked to commit to fight against treating ASB. Subsequently, the superhero name was used for blinded comparison of antibiotic prescribing trends among peers.
The importance of antibiotic stewardship in the ambulatory care setting is increasingly recognized. We depict a stewardship initiative specific to ambulatory care, implemented at a health care system level, that meets the Joint Commission Standards first required in 2020.
Positive urine cultures from November 1, 2018, to October 31, 2019, served as the preimplementation group, and cultures from November 1, 2020, to October 31, 2021, served as the postimplementation group. A retrospective chart review and logistic regression model were used to compare the antibiotic prescribing rate in ASB before and after the intervention.
The campaign was associated with a 92% reduction in the odds of antibiotic prescribing (odds ratio 0.08 [95% CI 0.04-0.17]) compared with the preimplementation period controlling for baseline covariates.
The utilization of academic detailing, bundled with audit and feedback, decreased the treatment of ASB and improved the quality of care received.
尿液中存在细菌,但没有感染的症状,被归类为无症状性菌尿症(ASB)。尽管 ASB 很常见,但美国传染病学会的指南不鼓励对其进行治疗,因为大多数患者没有不良健康影响,也不会从抗生素药物中获益。尽管有这些指南,但 ASB 患者经常接受抗生素药物治疗,这表明需要采取抗菌药物管理干预措施。
本研究旨在描述一项抗菌药物管理活动,该活动旨在针对门诊环境中 ASB 的正确识别和管理。
实施了抗菌药物管理活动以促进处方行为的改变。一名学术联络员向初级保健医生(PCP)进行了教育推广。采用有力的对话传递重点关注 PCP 具体改进的关键信息。在就诊结束时,每位 PCP 都被赋予一个独特的“超级英雄”名字,并被要求承诺对抗治疗 ASB。随后,使用超级英雄的名字对同行之间的抗生素处方趋势进行盲法比较。
抗菌药物管理在门诊环境中的重要性日益得到认可。我们描述了一项特定于门诊的管理计划,该计划在医疗保健系统层面实施,符合 2020 年首次要求的联合委员会标准。
2018 年 11 月 1 日至 2019 年 10 月 31 日的阳性尿液培养物作为实施前组,2020 年 11 月 1 日至 2021 年 10 月 31 日的培养物作为实施后组。使用回顾性图表审查和逻辑回归模型比较干预前后 ASB 中抗生素的使用率。
与实施前相比,该活动使抗生素使用的可能性降低了 92%(比值比 0.08 [95%CI 0.04-0.17]),同时控制了基线协变量。
学术细节、审计和反馈相结合的使用降低了 ASB 的治疗率,并提高了所接受的护理质量。